These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25781895)

  • 21. CTL induction by cross-priming is restricted to immunodominant epitopes.
    Pavelic V; Matter MS; Mumprecht S; Breyer I; Ochsenbein AF
    Eur J Immunol; 2009 Mar; 39(3):704-16. PubMed ID: 19189311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct loading of CTL epitopes onto MHC class I complexes on dendritic cell surface in vivo.
    Wang P; Dong S; Zhao P; He X; Chen M
    Biomaterials; 2018 Nov; 182():92-103. PubMed ID: 30107273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune hierarchy among HIV-1 CD8+ T cell epitopes delivered by dendritic cells depends on MHC-I binding irrespective of mode of loading and immunization in HLA-A*0201 mice.
    Kloverpris HN; Karlsson I; Thorn M; Buus S; Fomsgaard A
    APMIS; 2009 Nov; 117(11):849-55. PubMed ID: 19845536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells.
    Ayinde D; Bruel T; Cardinaud S; Porrot F; Prado JG; Moris A; Schwartz O
    J Virol; 2015 Jul; 89(14):6994-7006. PubMed ID: 25926647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS.
    Kawashima Y; Satoh M; Oka S; Shirasaka T; Takiguchi M
    Biochem Biophys Res Commun; 2008 Feb; 366(3):612-6. PubMed ID: 18035044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
    Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection.
    Keane NM; Roberts SG; Almeida CA; Krishnan T; Chopra A; Demaine E; Laird R; Tschochner M; Carlson JM; Mallal S; Heckerman D; James I; John M
    Immunol Cell Biol; 2012 Feb; 90(2):224-34. PubMed ID: 21577229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.
    Borzooee F; Joris KD; Grant MD; Larijani M
    Front Immunol; 2018; 9():3032. PubMed ID: 30687306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
    Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    Yu XG; Addo MM; Rosenberg ES; Rodriguez WR; Lee PK; Fitzpatrick CA; Johnston MN; Strick D; Goulder PJ; Walker BD; Altfeld M
    J Virol; 2002 Sep; 76(17):8690-701. PubMed ID: 12163589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection.
    Hay CM; Ruhl DJ; Basgoz NO; Wilson CC; Billingsley JM; DePasquale MP; D'Aquila RT; Wolinsky SM; Crawford JM; Montefiori DC; Walker BD
    J Virol; 1999 Jul; 73(7):5509-19. PubMed ID: 10364299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
    Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
    J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    Yusim K; Kesmir C; Gaschen B; Addo MM; Altfeld M; Brunak S; Chigaev A; Detours V; Korber BT
    J Virol; 2002 Sep; 76(17):8757-68. PubMed ID: 12163596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.
    Liu Y; McNevin J; Zhao H; Tebit DM; Troyer RM; McSweyn M; Ghosh AK; Shriner D; Arts EJ; McElrath MJ; Mullins JI
    J Virol; 2007 Nov; 81(22):12179-88. PubMed ID: 17728222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
    Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
    J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential selection pressure exerted on HIV by CTL targeting identical epitopes but restricted by distinct HLA alleles from the same HLA supertype.
    Leslie A; Price DA; Mkhize P; Bishop K; Rathod A; Day C; Crawford H; Honeyborne I; Asher TE; Luzzi G; Edwards A; Rousseau CM; Mullins JI; Tudor-Williams G; Novelli V; Brander C; Douek DC; Kiepiela P; Walker BD; Goulder PJ
    J Immunol; 2006 Oct; 177(7):4699-708. PubMed ID: 16982909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.